Plant Defense and Viral Counter-Defense Mechanisms Regulating Symptom Recovery, an Inducible Form of Plant Tolerance to Virus Infection

C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

Plant viruses are obligate parasites that highjack the resources of the host to facilitate their infection cycle.  Plants defend themselves using a variety of mechanisms, including antiviral RNA silencing.  Viruses counteract these defense responses, by encoding specialized proteins such as suppressors of silencing.  In some plant-virus interactions, notably in plants infected with nepoviruses, symptom recovery is observed.  In this complex phenotype, plants are initially diseased but later recover from infection and become asymptomatic.  Symptom recovery can be considered as a form of inducible tolerance in which the virus persists but does not cause significant disease.  Using Nicotiana benthamiana plants infected with tomato ringspot virus (ToRSV) as a model system, we have shown that symptom recovery is dependent on environmental conditions and on the specific ToRSV strain.  In this pathosystem, the plant antiviral RNA silencing is activated to reduce but not eliminate virus infection.  Temperature-dependent symptom recovery against a severe strain of ToRSV was shown to be associated with specific repression of the translation of viral RNAs, preventing the formation of viral proteins.  This process was dependent on the plant ARGONAUTE 1 (AGO1), a key enzyme of the antiviral RNA silencing mechanism.  A suppressor of silencing encoded by ToRSV was shown to counteract the AGO1-dependent translation repression mechanism although inefficiently.  In contrast, symptom recovery against a mild strain of ToRSV at a lower temperature did not depend on AGO1.  AGO2 restricted virus accumulation under these conditions but was not absolutely required for symptom recovering, suggesting that other AGOs are also likely to be involved.  The results highlight the complexity and diversity of molecular mechanisms associated with symptom recovery and illustrate how the delicate balance between plant defense responses and virus counter-defenses determines the outcome from infection. 

 

Learning Objectives:

1. Understand the diversity and complexity of plant antiviral defense mechanisms, in particular antiviral RNA silencing

2. Understand how the balance between plant defense responses and viral counter-defenses determine the outcome from infection from susceptibility to tolerance to resistance

3. Understand that redundant and overlapping defense mechanisms can simultaneously operate in virus-infected plants

4. Understand the impact of environmental factors on plant virus-induced disease
 


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
JUN 17, 2021 11:00 AM PDT
C.E. CREDITS
JUN 17, 2021 11:00 AM PDT
Date: June 17, 2021 Time: 11:00am PDT, 8:00pm CET BACKGROUND Kidney transplant recipients and patients on hemodialysis are immunocompromised populations excluded from vaccine trials. Data ar...
Loading Comments...
Show Resources